Bausch Health Companies Inc. (BHC): Cash & Equivalents
$1.31B
As of 2025-12-31
$1.82B
As of 2026-06-30
+32.4%
3-year compound annual growth
+16.7%
5-year compound annual growth
+8.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.31B | +10.8% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $1.18B | +24.7% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $947.00M | +67.9% | 2026-02-19, Balance as of period end |
| 2022-12-31 | $564.00M | -3.1% | 2025-02-20, Balance as of period end |
| 2021-12-31 | $582.00M | -3.8% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $605.00M | -81.3% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $3.24B | +349.8% | 2022-02-23, Balance as of period end |
| 2018-12-31 | $721.00M | +0.1% | 2021-02-24, Balance as of period end |
| 2017-12-31 | $720.00M | +32.8% | 2020-02-19, Balance as of period end |
| 2016-12-31 | $542.00M | -9.2% | 2019-02-20, Balance as of period end |
| 2015-12-31 | $597.00M | +84.8% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $323.00M | -46.2% | 2017-03-01, Balance as of period end |
| 2013-12-31 | $600.30M | -34.5% | 2016-04-29, Balance as of period end |
| 2012-12-31 | $916.10M | +458.2% | 2015-02-25, Balance as of period end |
| 2011-12-31 | $164.11M | -58.4% | 2014-02-28, Balance as of period end |
| 2010-12-31 | $394.27M | +244.5% | 2013-02-28, Balance as of period end |
| 2009-12-31 | $114.46M | -64.0% | 2012-02-29, Balance as of period end |
| 2008-12-31 | $317.55M | n/a | 2011-02-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.31B | +10.8% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $5.08B | +11.3% |
| Viatris Inc (VTRS) | 2025-12-31 | $1.32B | +80.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.12B | +25.3% |
| Organon & Co. (OGN) | 2025-12-31 | $574.00M | -15.0% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $3.56B | +7.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.39B | -42.3% |
Compare BHC, VRTX, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗